Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
Part of paid clinical trials in Redwood City, California.
- Sponsor
- HepQuant, LLC
- Study ID
- NCT07060547
- Status
- Recruiting
Conditions
- Alcohol-related Liver Disease
- Alcoholic Hepatitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- HepQuant DuO Test — DEVICEHepQuant DuO is commercially available in the U.S. as a Laboratory Developed Test (LDT), but it will be used in this study as a nonsignificant risk investigational device to measure change in liver function over time.
Study Details
This is a study to measure liver recovery in patients with recent alcohol-associated liver injury by assessing liver function and physiology using HepQuant DuO. The HepQuant DuO Test is a blood-based test that involves a drink of a natural compound, cholate, and 2 blood samples at 20 and 60 minutes. The study team is collecting clinical and laboratory data to better monitor and treat patients who have been affected by alcohol-associated liver disease. The study has 4 visits at an outpatient clinic at 1, 3, 6, and 12 months. At each of these visits, participants will undergo a HepQuant DuO test and other standard tests. In addition, the study team will ask about a participant's alcohol use, symptoms, and quality of life.
Key Dates
- Start date
- Jun 10, 2025
- Status verified
- Jul 2025
- Primary completion
- Dec 31, 2031
- Completion
- Mar 31, 2032
Study Design
- Enrollment
- 40 participants (estimated)
Primary Outcome Measure
Change in HepQuant Disease Severity Index (DSI) over time in patients with ALD [ Time Frame: From enrollment to 1 year past enrollment ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University Dept. of Medicine -Gastroenterology & Hepatology | Redwood City | California | 94063 | Allison Kwong, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Redwood City, CA
Related Studies
- Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAHRecruiting · Johns Hopkins University · Baltimore, Maryland
- Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic HepatitisRecruiting · The Cleveland Clinic · Cleveland, Ohio
- Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic HepatitisPHASE1/PHASE2 · Recruiting · Prasun Kumar Jalal · Houston, Texas
- HA35 Moderate Alcoholic Hepatitis (AH) StudyEARLY_PHASE1 · Recruiting · The Cleveland Clinic · Cleveland, Ohio